114 related articles for article (PubMed ID: 17176083)
1. Rapid conformational dynamics of cytochrome P450 2E1 in a natural biological membrane environment.
Smith SV; Robinson RC; Smith TG; Burks SM; Friedman FK
Biochemistry; 2006 Dec; 45(51):15617-23. PubMed ID: 17176083
[TBL] [Abstract][Full Text] [Related]
2. Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study.
Smith SV; Koley AP; Dai R; Robinson RC; Leong H; Markowitz A; Friedman FK
Biochemistry; 2000 May; 39(19):5731-7. PubMed ID: 10801323
[TBL] [Abstract][Full Text] [Related]
3. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics.
Koley AP; Robinson RC; Friedman FK
Biochimie; 1996; 78(8-9):706-13. PubMed ID: 9010599
[TBL] [Abstract][Full Text] [Related]
5. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
[TBL] [Abstract][Full Text] [Related]
7. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
Patten CJ; Koch P
Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of methyl tert-butyl ether and other gasoline ethers in mouse liver microsomes lacking cytochrome P450 2E1.
Hong JY; Wang YY; Bondoc FY; Yang CS; Gonzalez FJ; Pan Z; Cokonis CD; Hu WY; Bao Z
Toxicol Lett; 1999 Mar; 105(1):83-8. PubMed ID: 10092060
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.
Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
Chem Res Toxicol; 2002 Dec; 15(12):1561-71. PubMed ID: 12482238
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2E1 and its roles in disease.
Guengerich FP
Chem Biol Interact; 2020 May; 322():109056. PubMed ID: 32198084
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
Zhukov A; Ingelman-Sundberg M
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
[TBL] [Abstract][Full Text] [Related]
12. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
[TBL] [Abstract][Full Text] [Related]
14. Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation.
Lin HL; Myshkin E; Waskell L; Hollenberg PF
Chem Res Toxicol; 2007 Nov; 20(11):1612-22. PubMed ID: 17907788
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
[TBL] [Abstract][Full Text] [Related]
16. Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene.
Speerschneider P; Dekant W
Toxicol Appl Pharmacol; 1995 Jan; 130(1):48-56. PubMed ID: 7839370
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
[TBL] [Abstract][Full Text] [Related]
18. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s.
Asai H; Imaoka S; Kuroki T; Monna T; Funae Y
J Pharmacol Exp Ther; 1996 May; 277(2):1004-9. PubMed ID: 8627510
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory and noninhibitory monoclonal antibodies to human cytochrome P450 2E1.
Gelboin HV; Goldfarb I; Krausz KW; Grogan J; Korzekwa KR; Gonzalez FJ; Shou M
Chem Res Toxicol; 1996 Sep; 9(6):1023-30. PubMed ID: 8870991
[TBL] [Abstract][Full Text] [Related]
20. The high-affinity binding of [3H]norharman ([3H]beta-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver.
Stawowy P; Bonnet R; Rommelspacher H
Biochem Pharmacol; 1999 Mar; 57(5):511-20. PubMed ID: 9952314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
